# PreAsthmaControl (PAC)

> **NCT00234390** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 400 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Pulmicort (budesonide) pMDI

## Key facts

- **NCT ID:** NCT00234390
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 400 (—)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234390, "PreAsthmaControl (PAC)". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00234390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*